A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia
This study has been completed.
Study NCT00210769
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on September 13, 2005.
Last Updated on May 17, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
